-
06-08-2018, 08:27 AM
#281
Originally Posted by golden city
Capital raising on the way with 1.2m cash. Monthly losses about half million
March 2017 - $4.09m share placement at 16c
May 2017 - $900k SPP at 16c
Dec 2017 - $125k share option at 10c
Feb 2018 - $60k share option at 10c
Mar 2018 - $50k share option at 10c
Mar 2018 - $125k at 10c
April - $196k at 10c
April 2018 - $75k at 10c (with loan from company) so no net funds into TRU
Now why would the executives and directors put in any money in capital raisings when they can get all the shares they want at 10c?
-
20-08-2018, 03:16 PM
#282
Junior Member
Good addition to the board today.
-
20-08-2018, 04:01 PM
#283
Have to confess that I am a very slow learner as I lost money in the previous Aussie version. Going to areas with there isn't a vested interest in smear tests is a good strategy. Doctors seem no more capable of adapting new tech than any one else and appear no more ethical than the general population. One area for hope is that there now appear to be some new capable directors, whether they will hold the blow torch to the financials is another matter.
-
21-08-2018, 06:29 PM
#284
Member
Hey you cynics check this new director out. He’s the ducks nuts.
-
27-08-2018, 06:12 PM
#285
Junior Member
Interesting to see what happens here. Was not expecting the Africa angle.
-
27-08-2018, 10:40 PM
#286
Originally Posted by ofra002
Interesting to see what happens here. Was not expecting the Africa angle.
Sounding more and more like Plus SMS everyday!
-
28-08-2018, 09:36 AM
#287
Member
Originally Posted by Balance
Sounding more and more like Plus SMS everyday!
All that is missing now is for the CEO to come to an unfortunate demise!!
-
28-08-2018, 09:39 AM
#288
Originally Posted by Nice Option
All that is missing now is for the CEO to come to an unfortunate demise!!
Yup - throw plenty of humongous overseas opportunities out there with a product which does not even figure in any Western countries (esp NZ & Australia) and keep pumping out the good news.
-
28-08-2018, 01:03 PM
#289
Member
The company has deliberately targeted the developing countries because it is an effective means of testing in areas where health care is sparse and it has not had to overcome an entrenched pap smear infrastructure that exists in the West to prove its worth. This new director has good form and would not be interested if he did not see promise here. Happy with the progress and looking forward to more updates from China etc.
-
28-08-2018, 01:49 PM
#290
Originally Posted by Digs
The company has deliberately targeted the developing countries because it is an effective means of testing in areas where health care is sparse and it has not had to overcome an entrenched pap smear infrastructure that exists in the West to prove its worth. This new director has good form and would not be interested if he did not see promise here. Happy with the progress and looking forward to more updates from China etc.
.........yup, it's not rocket science DIGS, kind of obvious (to most). The whole concept behind the device is it's portability and application in remote areas that are lacking traditional medical infrastructure........possibly 2/3rds of the worlds population. Happy holder.
Tags for this Thread
Posting Permissions
- You may not post new threads
- You may not post replies
- You may not post attachments
- You may not edit your posts
-
Forum Rules
|
|
Bookmarks